Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 Expression in Patients with Non-Medullary Thyroid Cancer: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 Expression in Patients with Non-Medullary Thyroid Cancer: A Systematic Review and Meta-Analysis

Published:2018-03 Issue:3 Volume:28 Page:349-361
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Aghajani Marra¹²,Graham Susannah¹²³,McCafferty Charles²,Shaheed Christina Abdel⁴,Roberts Tara¹²⁵,DeSouza Paul¹²⁵,Yang Tao²⁶⁷,Niles Navin¹²³

Affiliation:

1. Department of Medical Oncology, Ingham Institute for Applied Medical Research, Liverpool, Australia.

2. School of Medicine, Western Sydney University, Campbelltown, Australia.

3. Department of Head and Neck Surgery, Liverpool Hospital, Liverpool, Australia.

4. Sydney School of Public Health, University of Sydney, Sydney, Australia.

5. South West Sydney Clinical School, UNSW Sydney, Sydney, Australia.

6. Saint Vincent's Clinical School, UNSW Sydney, Sydney, Australia.

7. SydPath, Saint Vincent's Hospital, Sydney, Australia.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2017.0441

Reference40 articles.

1. Thyroid cancer mortality and incidence: A global overview

2. AHIW 2014 Cancer in Australia: An Overview 2014. Australian Institute of Health and Welfare, Canberra, Australia, p 20.

3. International patterns and trends in thyroid cancer incidence, 1973–2002

4. Phenotypical Analysis of Lymphocytes with Suppressive and Regulatory Properties (Tregs) and NK Cells in the Papillary Carcinoma of Thyroid

5. American Association of Clinical Endocrinologists and American College of Endocrinology Disease State Clinical Review: The Increasing Incidence of Thyroid Cancer

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of CTLA-4 and PD-L1 Expression in Thyroid Carcinoma and Its Prognostic Significance;Cureus;2024-08-16

2. Predictive biomarkers in thyroid cancer in the current molecular-morphology paradigm;Surgical and Experimental Pathology;2024-08-14

3. Effects of CCT subunits on clinical prognosis and tumor microenvironment in thyroid cancer;2024-02-29

4. Leveraging molecular targeted drugs and immune checkpoint inhibitors treat advanced thyroid carcinoma to achieve thyroid carcinoma redifferentiation;American Journal of Cancer Research;2024

5. New Insights into Immune Cells and Immunotherapy for Thyroid Cancer;Immunological Investigations;2023-10-17